EC Number | Application | Comment | Organism |
---|---|---|---|
3.3.2.6 | pharmacology | leukotriene 4 hydrolase is a key target for the treatment of cardiovascular disease | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.3.2.6 | (R)-2-(4-benzylphenoxymethyl)pyrrolidine | - |
Homo sapiens | |
3.3.2.6 | (R)-2-[4-(4-chlorophenoxy)phenoxymethyl]pyrrolidine | - |
Homo sapiens | |
3.3.2.6 | 4-((R)-2-(4-(4-chlorophenoxy)phenoxymethyl)pyrrolidin-1-yl)-l-butyric acid | - |
Homo sapiens | |
3.3.2.6 | 4-((S)-2-[4-(4-chlorophenoxy)phenoxymethyl]pyrrolidin-1-yl)-butyric acid | - |
Homo sapiens | |
3.3.2.6 | 4-[(2S)-2-([4-(4-chlorophenoxy)phenoxy]methyl)-1-pyrrolidinyl]butanoic acid | i.e. DG-051 | Homo sapiens | |
3.3.2.6 | additional information | inhibitor structure-function analysis, overview | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.3.2.6 | microsome | - |
Homo sapiens | - |
- |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.3.2.6 | leukotriene A4 + H2O | Homo sapiens | - |
leukotriene B4 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.3.2.6 | Homo sapiens | P09960 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.3.2.6 | heart | - |
Homo sapiens | - |
3.3.2.6 | liver | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.3.2.6 | leukotriene A4 + H2O | - |
Homo sapiens | leukotriene B4 | - |
? | |
3.3.2.6 | leukotriene A4 + H2O | LTA4 | Homo sapiens | leukotriene B4 | LTB4 | ? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.3.2.6 | leukotriene A4 hydrolase | - |
Homo sapiens |
3.3.2.6 | LTA4H | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.3.2.6 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.3.2.6 | 8 | - |
assay at | Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.3.2.6 | 0.00003 | - |
- |
Homo sapiens | (R)-2-[4-(4-chlorophenoxy)phenoxymethyl]pyrrolidine | |
3.3.2.6 | 0.000047 | - |
- |
Homo sapiens | 4-((S)-2-[4-(4-chlorophenoxy)phenoxymethyl]pyrrolidin-1-yl)-butyric acid | |
3.3.2.6 | 0.000087 | - |
- |
Homo sapiens | (R)-2-(4-benzylphenoxymethyl)pyrrolidine |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.3.2.6 | metabolism | LTA4H is a key enzyme in the leukotriene pathway, which catalyzes the final and rate-determining step in the synthesis of LTB4 | Homo sapiens |